SBFM

SEC Filing Summary: Mountain West Business Solutions, Inc.

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended January 31, 2009, for Mountain West Business Solutions, Inc. (Note: The input metadata referenced "Sunshine Biopharma Inc.", but the filing text explicitly identifies the registrant as Mountain West Business Solutions, Inc.). The company is a development-stage entity incorporated in Colorado in August 2006. It intends to provide management consulting services regarding accounting, computer, and general business issues to small and home-office based companies, primarily in the Denver metropolitan area. As of the reporting date, the company has no active operations and is in the process of developing its business plan.

Key Financial Metrics

Liquidity: The company reported a net cash outflow from operating activities of $6,799 for the six months ended January 31, 2009. Financing activities provided $3,500 during the same period, primarily from notes payable.

Material Changes vs. Prior Period

• Revenue: Remained at $0 for both the three and six-month periods ended January 31, 2009, consistent with the prior year periods.
• Expenses: General and Administrative (G&A) expenses increased to $3,353 for the quarter ended Jan 31, 2009, compared to $2,265 in the prior year quarter. However, for the six-month period, G&A expenses decreased to $7,991 compared to $11,053 in the prior year.
• Net Loss: The quarterly net loss widened to $(3,793) from $(2,265) in the prior year. The six-month net loss narrowed slightly to $(10,371) from $(11,053).
• Cash Position: Cash and cash equivalents declined from $4,362 at July 31, 2008, to $1,063 at January 31, 2009.
• Debt: Current notes payable increased from $17,000 to $22,000.

Outlook, Risks, and Management Commentary

Plan of Operation: Management plans to offer hourly consulting, retainer contracts, and project consulting. They anticipate overhead costs will remain constant as revenues develop and aim to achieve profitability by the end of fiscal year 2009. Capital costs for the next 12 months are estimated at $10,000 to $12,000.

Liquidity and Capital Resources: The company is minimally capitalized. Management states that until operations become cash flow positive, officers and directors will fund operations. Mr. Milonas, the President, has agreed to loan necessary funds through December 31, 2009. There are no definitive plans for additional equity or debt financing beyond these loans.

Risks and Contingencies:

• Going Concern: Accountants have expressed doubt about the company's ability to continue as a going concern due to continued net losses and lack of operating history.
• Profitability: There is no assurance the company will ever be profitable. Failure to generate sufficient revenue could lead to liquidation.
• Competition: The company faces intense competition from larger, more established firms with greater financial resources.
• Stock Liquidity: The stock trades on the OTC Bulletin Board as a "penny stock," subject to strict SEC rules that limit liquidity. Approximately 99% of outstanding shares are restricted from immediate resale.
• Key Person Risk: Operations depend heavily on Mr. Milonas; there are no written employment agreements or key man insurance.

Investor Verification Checklist

• Going Concern Status: Verify the company's ability to secure funding beyond the President's personal loans to sustain operations past December 2009.
• Revenue Generation: Confirm if any client contracts or revenue-generating activities have commenced since the filing date, as the company has generated $0 revenue since inception.
• Debt Obligations: Review the terms of the $22,000 in notes payable to understand repayment schedules and interest rates.
• Stock Restrictions: Note that 99% of shares are restricted, which may severely impact the ability to liquidate an investment.
• Management Commitment: Assess the reliance on a single individual (Mr. Milonas) for all operational decisions and funding.